GLP-1 and GLP-1 analogues are effective in reducing hunger scores and weight when given to rodents and humans, and GLP-1 is a potent incretin, forming the basis for new treatments of diabetes mellitus. The gene discussed is GLP1R; the disease is diabetes mellitus.